Tag

Vaccines

All articles tagged with #vaccines

Lilly expands infectious-disease portfolio with three-broker vaccine acquisitions
business13 hours ago

Lilly expands infectious-disease portfolio with three-broker vaccine acquisitions

Eli Lilly is buying Curevo, LimmaTech Biologics, and Vaccine Company for up to $3.8 billion in upfront and milestone payments to broaden its infectious-disease pipeline. Curevo brings a shingles vaccine candidate, LimmaTech adds a Staphylococcus aureus vaccine program, and Vaccine Company offers vaccines targeting flaviviruses and an EBV-focused program, signaling Lilly’s shift toward preventative vaccines and a strategy to build a diversified vaccine portfolio alongside its strong oncology and metabolic franchises.

Elsevier retracts vaccine-SIDS study over flawed VAERS analysis
health14 hours ago

Elsevier retracts vaccine-SIDS study over flawed VAERS analysis

Elsevier has retracted a 2021 Toxicology Reports study by Neil Z. Miller that claimed most Sudden Infant Death Syndrome (SIDS) cases followed vaccination, citing serious methodological flaws in using VAERS data to infer causality and potential public‑health risk. The Editor-in-Chief removed the paper after concerns about the analysis were deemed unresolved, despite Miller’s opposition. The incident adds to a pattern of VAERS-based retractions; VAERS is intended for signal generation rather than establishing causality. A PDF with a “removed” watermark remained visible due to a publishing error.

Lilly bets on prevention with three biotech acquisitions
business1 day ago

Lilly bets on prevention with three biotech acquisitions

Lilly announced agreements to acquire Curevo, LimmaTech Biologics and Vaccine Company to broaden its infectious-disease portfolio with vaccine-based prevention for shingles, bacterial pathogens and EBV-related disease, respectively. The deals could total up to $3.83 billion in potential cash payments, contingent on milestones and regulatory clearances, and closing is subject to customary conditions, reflecting Lilly's strategy to prevent disease at the source and address antimicrobial resistance.

Lilly bets on prevention with triple acquisitions to boost infectious-disease portfolio
business1 day ago

Lilly bets on prevention with triple acquisitions to boost infectious-disease portfolio

Lilly will acquire Curevo, LimmaTech Biologics, and Vaccine Company to broaden its infectious-disease portfolio, spanning a shingles vaccine candidate, a bacterial-pathogen vaccine platform, and an EBV-focused virus-like particle vaccine, for up to about $3.83 billion in cash and milestone payments, subject to closing conditions.

Lilly bets $4B on infectious-disease push with three acquisitions
business1 day ago

Lilly bets $4B on infectious-disease push with three acquisitions

Eli Lilly said it will buy Curevo, LimmaTech Biologics and The Vaccine Company for almost $4 billion in cash to expand infectious-disease R&D, sending its shares higher in premarket trading. Curevo develops a shingles vaccine, LimmaTech targets resistant bacterial pathogens including STIs, and The Vaccine Company advances in vivo nanoparticle delivery technologies for drugs, genes, and diagnostics. The move comes as Lilly relies on Zepbound and Mounjaro for strong revenue and introduces Foundayo to compete with Novo Nordisk in obesity treatments.

Danish Vaccine Theories Step Into the RFK Jr. Policy Spotlight
health9 days ago

Danish Vaccine Theories Step Into the RFK Jr. Policy Spotlight

Danish researchers Peter Aaby and Christine Benn have long argued that vaccines confer non-specific effects that alter overall child survival, a claim that has drawn both praise and fierce criticism. With RFK Jr. shaping US vaccine policy, their work gained political traction, helping justify significant funding shifts and sparking ethical and methodological scrutiny in Denmark. A Bandim Health Project hepatitis B birth-dose study in Guinea-Bissau is paused amid ethics concerns, while independent studies and WHO positions remain skeptical of the broader non-specific effects claim. The article traces how science, funding, and politics intersect as the debate intensifies.

Hantavirus vaccines edge closer, but rollout remains years away
health10 days ago

Hantavirus vaccines edge closer, but rollout remains years away

Hantavirus currently has no cure and treatment is supportive. Global researchers are developing vaccines (including EnsiliTech and Moderna) targeting American strains; animal studies show promise, but human trials and regulatory approval will take years. The recent outbreak on a luxury cruise underscored its lethality, with mortality up to ~40% for hantavirus pulmonary syndrome and 1–12% for hemorrhagic fever with renal syndrome. Canada has logged 168 cases since 1994. If funding and political will align, a vaccine could reach high-risk groups within several years (roughly 3–4) after successful trials.

Travel Health Hacks Doctors Use to Stay Sick-Free on the Road
health10 days ago

Travel Health Hacks Doctors Use to Stay Sick-Free on the Road

Doctors share their own travel routines to avoid getting sick, highlighting masking in airports and planes, constant handwashing and sanitizing, staying hydrated with electrolytes, nasal mists and vitamin C for immunity, avoiding peak travel times, prioritizing rest, a balanced diet, pre-travel vaccines, and packing practical meds (anti-diarrheal, pain relievers, anti-nausea) for international trips.

US public health gaps leave nation unprepared for future outbreaks, experts warn
health10 days ago

US public health gaps leave nation unprepared for future outbreaks, experts warn

US public health has weakened since Covid, with staffing losses, funding cuts and testing/output bottlenecks that hinder outbreak response. Misinformation and eroding trust complicate risk communication, while global vaccine equity and international collaboration are at risk due to reduced federal leadership. Experts urge pre-bunking myths, clearer messaging, and renewed investment in public health infrastructure and international partnerships to be ready for a next pandemic potentially as bad as or worse than Covid within 25 years.

Border measles outbreak reveals vaccine gaps in Mexico and Texas
world10 days ago

Border measles outbreak reveals vaccine gaps in Mexico and Texas

An unvaccinated 9-year-old’s return from Seminole, Texas to Cuauhtémoc, Chihuahua sparked a large measles outbreak that spread across parts of Mexico and led to thousands of infections and dozens of deaths in 2025. The spread highlighted gaps in Mexico’s vaccination program amid budget cuts and health-system turmoil, along with pockets of vaccine hesitancy in the U.S. and among Indigenous farmworkers. A mass vaccination push helped curb cases in subsequent months, but public-health experts warn the threat remains in under-vaccinated communities and regions.

RFK Jr. Tries Out Surgical Robot Console During Open-Heart Procedure
politics13 days ago

RFK Jr. Tries Out Surgical Robot Console During Open-Heart Procedure

RFK Jr. joined Donald Trump’s health-tour in Ohio and briefly sat at a robotic-surgery console during an open-heart operation, with reports that the robotic hands were disconnected from the patient; a later amendment clarified he did not operate the robot. The episode occurred as Kennedy—long a vaccine skeptic—pursues a broader MAHA-themed campaign and research efforts, drawing attention to the use of robotic-assisted surgery at the Cleveland Clinic.